Literature DB >> 22751857

[Diagnostics and exclusion of hereditary angioedema : a standarized approach for the practice].

M Magerl1, J Brasch, U Förster, B Hauswald, E B Mohr, B Mohr, J Prässler, R Treudler, R Vetter, V Wahn, V Zampeli, V Zampelli, M Ziemer, M Maurer.   

Abstract

The differentiation between mast cell mediator-mediated and bradykinin-mediated forms of angioedema can be difficult. Bradykinin-mediated hereditary angioedema is a rare autosomal dominant hereditary disease which is characterized by recurrent edema attacks of varying magnitude. The edema occurs in the skin and mucous membranes and can be temporarily disfiguring, very painful and life-threatening by attacks in the laryngeal region. Because of the multitude of differential diagnoses, a final diagnosis is only achieved after an average duration of more than 10 years. The anamnestic and laboratory diagnostic algorithm presented here is designed to assist a simpler differentiation of the various forms of angioedema and to reach the correct diagnosis more quickly.

Entities:  

Mesh:

Year:  2012        PMID: 22751857     DOI: 10.1007/s00105-012-2388-x

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  37 in total

Review 1.  Acquired angioedema: Autoantibody associations and C1q utility as a diagnostic tool.

Authors:  Seth Ilias Breitbart; Leonard Bielory
Journal:  Allergy Asthma Proc       Date:  2010 Sep-Oct       Impact factor: 2.587

2.  Computed tomography of the gastrointestinal manifestation of hereditary angioedema.

Authors:  Masaki Wakisaka; Mitsutaka Shuto; Hisanori Abe; Masaaki Tajima; Hidefumi Shiroshita; Toshio Bandoh; Tsuyoshi Arita; Michio Kobayashi; Tomoko Nakayama; Fumito Okada; Hiromu Mori; Naoki Uemura
Journal:  Radiat Med       Date:  2009-01-08

3.  Successful treatment of hereditary angioedema with bradykinin B2-receptor antagonist icatibant.

Authors:  Karoline Krause; Martin Metz; Torsten Zuberbier; Marcus Maurer; Markus Magerl
Journal:  J Dtsch Dermatol Ges       Date:  2009-09-16       Impact factor: 5.584

4.  Ecallantide for the treatment of acute attacks in hereditary angioedema.

Authors:  Marco Cicardi; Robyn J Levy; Donald L McNeil; H Henry Li; Albert L Sheffer; Marilyn Campion; Patrick T Horn; William E Pullman
Journal:  N Engl J Med       Date:  2010-08-05       Impact factor: 91.245

5.  Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema.

Authors:  Bruce L Zuraw; Paula J Busse; Martha White; Joshua Jacobs; William Lumry; James Baker; Timothy Craig; J Andrew Grant; David Hurewitz; Leonard Bielory; William E Cartwright; Majed Koleilat; Walter Ryan; Oren Schaefer; Michael Manning; Pragnesh Patel; Jonathan A Bernstein; Roger A Friedman; Robert Wilkinson; David Tanner; Gary Kohler; Glenne Gunther; Robyn Levy; James McClellan; Joseph Redhead; David Guss; Eugene Heyman; Brent A Blumenstein; Ira Kalfus; Michael M Frank
Journal:  N Engl J Med       Date:  2010-08-05       Impact factor: 91.245

6.  Plasma bradykinin in angio-oedema.

Authors:  J Nussberger; M Cugno; C Amstutz; M Cicardi; A Pellacani; A Agostoni
Journal:  Lancet       Date:  1998-06-06       Impact factor: 79.321

7.  Factor XII mutations, estrogen-dependent inherited angioedema, and related conditions.

Authors:  Karen E Binkley
Journal:  Allergy Asthma Clin Immunol       Date:  2010-07-28       Impact factor: 3.406

Review 8.  Nonallergic angioedema: role of bradykinin.

Authors:  M Bas; V Adams; T Suvorava; T Niehues; T K Hoffmann; G Kojda
Journal:  Allergy       Date:  2007-08       Impact factor: 13.146

9.  Functional C1-inhibitor diagnostics in hereditary angioedema: assay evaluation and recommendations.

Authors:  Ineke G A Wagenaar-Bos; Christian Drouet; Emel Aygören-Pursun; Konrad Bork; Christoph Bucher; Anette Bygum; Henriette Farkas; George Fust; Hanna Gregorek; C Erik Hack; Alaco Hickey; Helen I Joller-Jemelka; Maria Kapusta; Wolfhart Kreuz; Hilary Longhurst; Margarita Lopez-Trascasa; Kazimierz Madalinski; Jerzy Naskalski; Ed Nieuwenhuys; Denise Ponard; Lennart Truedsson; Lilian Varga; Erik Waage Nielsen; Eric Wagner; Lorenza Zingale; Marco Cicardi; S Marieke van Ham
Journal:  J Immunol Methods       Date:  2008-07-23       Impact factor: 2.303

10.  Diagnosis and treatment of hereditary angioedema with normal C1 inhibitor.

Authors:  Konrad Bork
Journal:  Allergy Asthma Clin Immunol       Date:  2010-07-28       Impact factor: 3.406

View more
  1 in total

1.  Clinical similarities among bradykinin-mediated and mast cell-mediated subtypes of non-hereditary angioedema: a retrospective study.

Authors:  Karlijn J G Schulkes; Mignon T Van den Elzen; Erik C Hack; Henderikus G Otten; Carla A F M Bruijnzeel-Koomen; André C Knulst
Journal:  Clin Transl Allergy       Date:  2015-02-04       Impact factor: 5.871

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.